{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:56:06Z","timestamp":1790488566381,"version":"4.1.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00459","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T14:39:27Z","timestamp":1552574367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3+ Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis"],"prefix":"10.3389","volume":"10","author":[{"given":"Hirohito","family":"Abo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle L.","family":"Flannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duke","family":"Geem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu L.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Harusato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12026-013-8452-5","article-title":"The IL-2\/IL-2R system: from basic science to therapeutic applications to enhance immune regulation","volume":"57","author":"Bayer","year":"2013","journal-title":"Immunol Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1586\/1744666X.2014.875856","article-title":"Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy","volume":"10","author":"Skrombolas","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/1744666X.2017.1245146","article-title":"Therapy implications of the role of interleukin-2 in cancer","volume":"13","author":"Lissoni","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.131.4.1808","article-title":"Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics","volume":"131","author":"Smith","year":"1983","journal-title":"J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(02)00367-9","article-title":"CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2","volume":"17","author":"Malek","year":"2002","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1084\/jem.20020190","article-title":"Interleukin 2 signaling is required for CD4(+) regulatory T cell function","volume":"196","author":"Furtado","year":"2002","journal-title":"J Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function","volume":"172","author":"Thornton","year":"2004","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.20041179","article-title":"Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period","volume":"201","author":"Bayer","year":"2005","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/eji.200425274","article-title":"Interleukin-2 is essential for CD4+CD25+ regulatory T cell function","volume":"34","author":"de la Rosa","year":"2004","journal-title":"Eur J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J Exp Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/intimm\/10.4.371","article-title":"Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency","volume":"10","author":"Papiernik","year":"1998","journal-title":"Int Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J Autoimmun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","article-title":"Antibodies to Interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms","volume":"42","author":"Spangler","year":"2015","journal-title":"Immunity."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1182\/blood-2014-07-587493","article-title":"Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy","volume":"124","author":"Van Gool","year":"2014","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.immunol.021908.132657","article-title":"Regulatory lymphocytes and intestinal inflammation","volume":"27","author":"Izcue","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science."},{"key":"B27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni.2886","article-title":"The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells","volume":"15","author":"Obata","year":"2014","journal-title":"Nat Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","article-title":"Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene","volume":"75","author":"Sadlack","year":"1993","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1084\/jem.20101235","article-title":"A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota","volume":"207","author":"Chinen","year":"2010","journal-title":"J Exp Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.0105-2896.2005.00250.x","article-title":"Regulatory T cells and intestinal homeostasis","volume":"204","author":"Coombes","year":"2005","journal-title":"Immunol Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/MIB.0000000000000343","article-title":"Harnessing regulatory T cells for the treatment of inflammatory bowel disease","volume":"21","author":"Geem","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3389\/fimmu.2017.01460","article-title":"Engineered tolerance: tailoring development, function, and antigen-specificity of regulatory T cells","volume":"8","author":"Dawson","year":"2017","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2015.07.008","article-title":"Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitis","volume":"43","author":"Griseri","year":"2015","journal-title":"Immunity."},{"key":"B36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cyto.a.22012","article-title":"A novel Ly6C\/Ly6G-based strategy to analyze the mouse splenic myeloid compartment","volume":"81","author":"Rose","year":"2012","journal-title":"Cytometry A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nm.3892","article-title":"Innate lymphoid cells in the initiation, regulation and resolution of inflammation","volume":"21","author":"Sonnenberg","year":"2015","journal-title":"Nat Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Klein Wolterink","year":"2012","journal-title":"Eur J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ni.2584","article-title":"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells","volume":"14","author":"Roediger","year":"2013","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.iac.2008.10.004","article-title":"Functional role of eosinophils in gastrointestinal inflammation","volume":"29","author":"Hogan","year":"2009","journal-title":"Immunol Allergy Clin North Am."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/gut.2005.072595","article-title":"The role of eosinophils in inflammatory bowel disease","volume":"54","author":"Al-Haddad","year":"2005","journal-title":"Gut."},{"key":"B43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4049\/jimmunol.1400413","article-title":"Roles and regulation of gastrointestinal eosinophils in immunity and disease","volume":"193","author":"Jung","year":"2014","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/MPG.0b013e3182128512","article-title":"Role of eosinophils in inflammatory bowel and gastrointestinal diseases","volume":"52","author":"Woodruff","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.4049\/jimmunol.181.10.7390","article-title":"Intestinal macrophage\/epithelial cell-derived CCL11\/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis","volume":"181","author":"Ahrens","year":"2008","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2353\/ajpath.2010.100191","article-title":"CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis","volume":"177","author":"Maltby","year":"2010","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.2353\/ajpath.2009.090093","article-title":"Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis","volume":"175","author":"Vieira","year":"2009","journal-title":"Am J Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/gutjnl-2014-306998","article-title":"Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis","volume":"64","author":"Masterson","year":"2015","journal-title":"Gut."},{"key":"B49","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.immuni.2014.02.014","article-title":"Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis","volume":"40","author":"Chu","year":"2014","journal-title":"Immunity."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.4049\/jimmunol.172.9.5664","article-title":"Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase","volume":"172","author":"Forbes","year":"2004","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.gene.6363654","article-title":"Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice","volume":"1","author":"Stevceva","year":"2000","journal-title":"Genes Immun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/mi.2015.2","article-title":"Eosinophils in mucosal immune responses","volume":"8","author":"Travers","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature."},{"key":"B54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2018.05.014","article-title":"A metabolite-triggered tuft cell-ILC2 circuit drives small intestinal remodeling","volume":"174","author":"Schneider","year":"2018","journal-title":"Cell."},{"key":"B55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.immuni.2018.06.016","article-title":"Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit","volume":"49","author":"Nadjsombati","year":"2018","journal-title":"Immunity."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1126\/science.aaf1648","article-title":"Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut","volume":"351","author":"Howitt","year":"2016","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: biology, design and application","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cytogfr.2016.02.002","article-title":"IL-9 signaling as key driver of chronic inflammation in mucosal immunity","volume":"29","author":"Neurath","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.2174\/13894501113149990170","article-title":"Anti-IL-13 in inflammatory bowel disease: from the bench to the bedside","volume":"14","author":"Jovani","year":"2013","journal-title":"Curr Drug Targets."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.4049\/jimmunol.1200057","article-title":"Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA\/p65 in mice","volume":"190","author":"Waddell","year":"2013","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e9178","DOI":"10.1371\/journal.pone.0009178","article-title":"IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells","volume":"5","author":"Yamasaki","year":"2010","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J Exp Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:04:39Z","timestamp":1694700279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2019.00459"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00459","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"article-number":"459"}}